We are live on
!
Find out more
S
SignatureFD Portfolio holdings
AUM
$7.49B
1-Year Est. Return
24.82%
This Fund
S&P 500
This Quarter
Est. Return
+6.43%
1 Year Est. Return
+24.82%
3 Year Est. Return
+73.56%
5 Year Est. Return
+79.97%
10 Year Est. Return
+256.52%
AUM
$1.35B
AUM Growth
+$137M
(+11%)
Cap. Flow
+$72.8M
Cap. Flow
% of AUM
5.38%
Top 10 Holdings %
Top 10 Hldgs %
59.71%
Holding
2,379
New
211
Increased
969
Reduced
524
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$22.2M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$15.4M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$8.08M |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
+$7.77M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$6.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MLPI
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
|
+$43M |
| 2 |
Lowe's Companies
LOW
|
+$7.18M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$1.87M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$1.33M |
| 5 |
BWX Technologies
BWXT
|
+$1.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.71% |
| 2 | Technology | 5.69% |
| 3 | Consumer Staples | 4.7% |
| 4 | Consumer Discretionary | 4.47% |
| 5 | Healthcare | 4.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Boeing
BA
$165B
| $2.23M | 0.16% |
6,836
+2,389
| +54% | +$846K |
|
52
Bristol-Myers Squibb
BMY
$127B
| $2.21M | 0.16% |
34,496
+15,063
| +78% | +$863K |
|
53
Alibaba
BABA
$269B
| $2.2M | 0.16% |
10,367
+1,341
| +15% | +$252K |
|
54
TSMC
TSM
$2.09T
| $2.08M | 0.15% |
35,847
+4,527
| +14% | +$240K |
|
55
Haverty Furniture Companies
HVT
$401M
| $2.07M | 0.15% |
102,561
| – | – |
|
56
McDonald's
MCD
$188B
| $2.06M | 0.15% |
10,407
+488
| +5% | +$96.8K |
|
57
Altria Group
MO
$122B
| $1.98M | 0.15% |
39,592
+8,831
| +29% | +$417K |
|
|
RDS.A
58
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.89M | 0.14% |
32,019
+12,298
| +62% | +$718K |
|
59
Novartis
NVS
$295B
| $1.89M | 0.14% |
19,936
+4,348
| +28% | +$390K |
|
60
Mastercard
MA
$477B
| $1.87M | 0.14% |
6,261
+457
| +8% | +$129K |
|
61
Eli Lilly
LLY
$1.07T
| $1.86M | 0.14% |
14,165
+7,527
| +113% | +$872K |
|
|
62
BWX Technologies
BWXT
$16B
| $1.84M | 0.14% |
29,718
-19,435
| -40% | -$1.15M |
|
63
Chevron
CVX
$388B
| $1.84M | 0.14% |
15,278
-969
| -6% | -$114K |
|
|
FLG
64
Flagstar Bank National Association
FLG
$5.77B
| $1.82M | 0.13% |
50,377
-14,834
| -23% | -$548K |
|
65
Vanguard FTSE Developed Markets ETF
VEA
$226B
| $1.79M | 0.13% |
40,663
-500
| -1% | -$21.3K |
|
66
Amgen
AMGN
$203B
| $1.79M | 0.13% |
7,429
+702
| +10% | +$155K |
|
67
Comcast
CMCSA
$79.1B
| $1.78M | 0.13% |
39,520
+1,935
| +5% | +$86.1K |
|
68
Northrop Grumman
NOC
$77B
| $1.77M | 0.13% |
5,149
+1,036
| +25% | +$364K |
|
69
Golub Capital BDC
GBDC
$3.33B
| $1.75M | 0.13% |
97,113
+1,735
| +2% | +$30.6K |
|
70
SPDR Gold Trust
GLD
$131B
| $1.74M | 0.13% |
12,189
+6,755
| +124% | +$944K |
|
71
Vanguard High Dividend Yield ETF
VYM
$81.1B
| $1.74M | 0.13% |
18,592
+6,656
| +56% | +$604K |
|
72
NextEra Energy
NEE
$187B
| $1.73M | 0.13% |
28,564
+696
| +2% | +$40.6K |
|
73
Wells Fargo
WFC
$261B
| $1.72M | 0.13% |
31,888
+830
| +3% | +$43.5K |
|
74
iShares Russell Mid-Cap ETF
IWR
$56.8B
| $1.65M | 0.12% |
27,598
+10,750
| +64% | +$617K |
|
75
AstraZeneca
AZN
$263B
| $1.64M | 0.12% |
16,431
+9,042
| +122% | +$851K |
|
Similar funds
JF
YAM
ASN
AIM
OPERF
SP
BIM
AMH
SignatureFD's Q4 2019 Portfolio in Review
As of Q4 2019, SignatureFD held 2,379 positions worth $1.35B, up 11% from $1.22B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
SignatureFD deployed $72.8M of net new capital in Q4 2019, opening 211 new positions and adding to 969 existing holdings. Its largest new stake was Castle Biosciences: 16,132 shares worth $554K.
By sector, the portfolio is most concentrated in Financials at 5.7% of assets, down from 5.8% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was UBS E-TRACS Alerian MLP Infrastructure ETN, an estimated $43M trimmed.
- SignatureFD's largest Q4 2019 buy was Castle Biosciences: 16,132 shares worth $554K.
- SignatureFD added most to iShares MSCI USA Value Factor ETF in Q4 2019, an estimated $22.2M increase.
- SignatureFD's biggest Q4 2019 reduction was UBS E-TRACS Alerian MLP Infrastructure ETN, cutting an estimated $43M.
- SignatureFD fully exited Berkshire Hathaway Class A in Q4 2019, selling an estimated $1.87M.
- SignatureFD's ten largest holdings make up 60% of its $1.35B portfolio in Q4 2019.
- SignatureFD opened 211 new positions and closed 145 in Q4 2019.
- SignatureFD's portfolio value rose 11% quarter-over-quarter to $1.35B.
Based on SignatureFD's 13F filing for Q4 2019, filed 5 Feb 2020.